Carcinogenesis In Experimental Animals Research Articles

Enhancement of tumor response to gamma-radiation by an inhibitor of cyclooxygenase-2 enzyme.

Enhancement of tumor response to gamma-radiation by an inhibitor of cyclooxygenase-2 enzyme.

The extracellular matrix in skin tumor development-a morphological study.

The development of cancer involves epithelial-stromal interactions. Alterations in the synthesis and deposition of type I and III collagens are related to the tumor morphology. Skin carcinogenesis in experimental animals provides a reliable model for the development of neoplasia. Ultraviolet (UV) irradiation is the main etiological factor for epidermal dysplasia and malignant tumors in man, but also for dermal degeneration. Non-neoplastic dermal changes and skin tumors induced by ultraviolet irradiation and 7,12-dimethylbenz(a)anthracene were investigated in various mouse strains with different susceptibilities to tumor formation. UVB irradiation resulted in an increased immunoreactivity of collagens in the dermis, in comparison with 7,12-dimethylbenz(a)anthracene. Increased synthesis and deposition of type I and III collagens were found in the stroma adjacent to benign alterations. In well-differentiated squamous cell carcinomas, a similar induction of collagen synthesis and deposition was observed. The destruction of fibrillary structures was more pronounced during the decrease of differentiation from moderately to poorly differentiated squamous cell carcinomas. Anaplastic carcinomas with spindle cell morphology displayed a delicate meshwork of reticular fibers and collagen III, and abnormal expression of mRNA for collagens in some malignant cells with epithelial characteristics. The underlying stroma reacts to the development of epithelial tumors in a reproducible way, which is related to the carcinogenic agent involved.

Dietary fibres may protect or enhance carcinogenesis

Dietary fibre (DF) is widely considered to protect against cancer, especially colorectal cancer. However, a large prospective epidemiological study has shown no apparent effect of DF intake on the development of colorectal cancer. We suggest that this may be because the term DF represents a wide range of materials, some able to protect, but some able to enhance carcinogenesis. This is consistent with data from animal carcinogenesis experiments. Most of the DF in western diets is in the form of plant cell walls, but these vary in their composition and it is unlikely that all types are protective. The few data available indicate that plant cell walls containing suberin or lignin may be the most protective, although they are present in only small amounts in food plants. DFs are also added to foods. These include components obtained from plant cell walls, such as pectins, as well as soluble DFs from other sources. In general, animal carcinogenesis experiments indicate that soluble DFs do not protect and some may enhance carcinogenesis. Few human intervention studies have been done on DF or sources of DF, with the exception of wheat bran, a good source of DF, which has been shown to protect. Possible mechanisms whereby DF may enhance carcinogenesis are discussed. In addition to DFs, resistant starches and non-digestible oligosaccharides are added to foods; these, like DF, escape digestion in the small intestine. However, so far only a few animal carcinogenesis experiments have been reported using these materials, and no human intervention studies. We believe caution should be exercised in the addition of such materials to food.

Epithelial Cell Hyperproliferation After Biliopancreatic Reflux Into the Esophagus of Rats

Background. Chronic reflux of duodenal contents into the esophagus of rats produces severe esophagitis and exerts a co-carcinogenic effect on the proliferating cells by enhancing the formation of nitrosamine-induced esophageal carcinomas. We investigated the effect of the different components of the duodenal reflux on the epithelial cell proliferation of the lower esophagus.Methods. Sprague-Dawley rats underwent three surgical reflux models (biliopancreatic, pancreatic, and biliary) and a sham operation. Animals were sacrificed at 72 hours, 6 weeks, and 9 weeks after the operation. Histology and cell proliferation, determined by ornithine decarboxylase activity, polyamine (putrescine, spermidine, spermine) levels, and proliferating cell nuclear antigen labeling index of the basal and suprabasal layers, were studied in the distal esophagus.Results. Both biliopancreatic and pancreatic reflux induced severe esophagitis starting on week 6. Suprabasal proliferating cell nuclear antigen labeling index significantly increased throughout the 9 weeks of the study in the biliopancreatic and pancreatic reflux groups, although this increase was earlier in the former group. Ornithine decarboxylase activity and polyamine levels were significantly increased in the biliopancreatic and pancreatic groups on week 6, decreasing on week 9.Conclusions. Increased esophageal cell proliferation after both biliopancreatic and pancreatic reflux into the lower esophagus may therefore be one mechanism by which duodenal-content reflux stimulates esophageal carcinogenesis in experimental animals.

Topics in cancer risk assessment.

The estimation of carcinogenic risks from exposure to chemicals has become an integral part of the regulatory process in the United States within the past decade. With it have come considerable controversy and debate over the scientific merits and shortcomings of the methods and their impact on risk management decisions. In this paper we highlight selected topics of current interest in the debate. As an indication of the level of public concern, we note the major recent reports on risk assessment from the National Academy of Sciences and the U.S Environmental Protection Agency's proposed substantial revisions to its Guidelines for Carcinogen Risk Assessment. We identify and briefly frame several key scientific issues in cancer risk assessment, including the growing recognition of the importance of understanding the mode of action of carcinogenesis in experimental animals and in humans, the methodologies and challenges in quantitative extrapolation of cancer risks, and the question of how to assess and account for human variability in susceptibility to carcinogens. In addition, we discuss initiatives in progress that may fundamentally alter the carcinogenesis testing paradigm.

Conjugated linoleic acid modulates hepatic lipid composition in mice.

Conjugated linoleic acid (CLA) is a chemoprotective fatty acid that inhibits mammary, colon, forestomach, and skin carcinogenesis in experimental animals. We hypothesize that the ubiquitous chemoprotective actions of dietary CLA in extrahepatic tissues are dependent upon its role in modulating fatty acid composition and metabolism in liver, the major organ for lipid metabolism. This study begins to evaluate the role of CLA in lipid metabolism by determining the modulation of fatty acid composition by CLA. Female SENCAR mice were fed semipurified diets containing 0.0% (Diet A), 0.5% (Diet B), 1.0% (Diet C), or 1.5% (Diet D) CLA (by weight) for six weeks. Mice fed Diets B, C, and D exhibited lower body weights and elevated amounts of extractable total lipid in livers compared with mice fed diets without CLA (Diet A). Analyses of the fatty acid composition of liver by gas chromatography revealed that dietary CLA was incorporated into neutral and phospholipids at the expense of linoleate in Diets B, C, and D; oleate increased and arachidonate decreased in neutral lipids of CLA diet groups. In addition, increasing dietary CLA was associated with reduced linoleate in hepatic phospholipids. In an in vitro assay, CLA was desaturated to an unidentified 18:3 product to a similar extent as linoleate conversion to gamma-linolenate (9.88, and 13.63%, respectively). These data suggest that CLA may affect metabolic interconversion of fatty acids in liver that may ultimately result in modified fatty acid composition and arachidonate-derived eicosanoid production in extrahepatic tissues. In addition to determining how dietary CLA modulates eicosanoid synthesis, further work is needed to identify enzymatic products that may result from desaturation of CLA.

A biologically based model for the analysis of premalignant foci of arbitrary shape

In many animal carcinogenesis experiments, quantitative data on putative premalignant foci are now routinely collected. Moolgavkar et al. [Carcinogenesis 11:1271 (1990)] considered the analysis of such data from a rat hepatocarcinogenesis experiment within the framework of a two-stage model for carcinogenesis using the assumption that the premalignant clones were spherical. This assumption seems questionable in many organs, including the liver. In this paper, it is relaxed and arbitrary shapes are allowed for the clones. The proposed method is illustrated by reanalysis of the data considered in the earlier paper. The new analysis yields parameter estimates that are more plausible biologically than those of the original analysis.

Dietary fat and breast cancer: controversy and biological plausibility.

The influence which dietary fat may exert on the development of breast cancer continues to provoke heated debate.1-5 The association between fat consumption and mammary carcinogenesis in experimental animals was first described by Tannenbaum over 50 years ago6 and has been confirmed repeatedly since then.7-9 In addition to influencing the promotional stage of carcinogenesis, dietary fat also affects the growth of transplantable rodent mammary carcinomas10-12 and of human breast cancer cells when injected into athymic nude mice.13-17

Testing Against Ordered Alternatives for Censored Survival Data

In animal carcinogenesis experiments or comparative clinical trials where the r groups correspond to increasing dosages of an agent or an increasing number of additional modalities and the primary outcome is time to a certain event (e.g., tumor occurrence, death) T, ordered alternatives of the form H1 : S1 ≤ S2 ≤ · · · ≤ Sr , where Si(t) = Pr (Ti > t) is the survival function for group are of special interest. Using the counting process formulation of the problem and generalizing earlier results, we show that the class of all two-sample weighted logrank statistics can be extended to test specifically for ordered alternatives. Ordered versions of the Gehan-Wilcoxon, unweighted logrank, and Peto–Prentice–Wilcoxon tests are investigated in detail. Asymptotic relative efficiencies under Lehmann and scale alternatives are evaluated analytically and numerically among these three tests and against Tarone's trend test (1975) for Weibull, gamma, and lognormal survival distributions. Effects of censoring and unequa...

Retinoids in cancer treatment.

Since initial studies identifying the important role of vitamin A and its derivatives (retinoids) in maintaining the integrity of epithelial tissues, these compounds have served as paradigms for experimental studies exploring the pharmacologic modification of carcinogenesis. Retinoids have clearly been shown to inhibit chemically induced mammary and urothelial carcinogenesis in experimental animals. Prohibitive toxicity of the parent compound, vitamin A, led to a systematic search for synthetic derivatives with an improved therapeutic index. More than 1500 such compounds have been synthesized, many retaining chemopreventive potential, but with less toxicity. Although several anecdotal reports confirming therapeutic benefits of cis-retinoic acid in patients with acute promyelocytic leukemia and myelodysplastic syndromes appeared in the late 1970s and early 1980s, the remarkable studies of Huang and his colleagues in China in 1988 reporting complete remissions in patients with this uncommon variety of acute myelogenous leukemia with the transisomer of retinoic acid (all-trans-retinoic acid) led to a resurgence of interest in the retinoids as differentiating agents for the prevention and therapy of cancer. Furthermore, molecular studies showing DNA rearrangements of the alpha nuclear receptor for retinoic acid located on chromosome 17 in patients with acute promyelocytic leukemia, a disease invariably associated with a translocation between chromosomes 15 and 17, provided a direct connection between an altered nuclear receptor and the development of a human malignancy. The retinoids also may have important beneficial effects in prevention of recurrent malignancies once the primary tumor has been treated, such as in squamous cell carcinoma of the head and neck. Because retinoids appear to be less effective in inducing differentiation in nonpromyelocytic leukemia cells, investigators have conducted a number of studies to exploit potential synergism between retinoids and other differentiating agents or biologic effectors. Differentiation therapy and chemoprevention are attractive alternative approaches to intensive cytotoxic chemotherapy. It is now clear that retinoids represent one class of compounds with which it may be possible to reverse the progression of malignant disease and prevent carcinogenesis.

Dietary modulation of experimental neoplastic development: role of fat and fiber content and calorie intake

Cancer is still one of the major causes of death in the industrialized countries but locally prevailing lifestyles may dictate the kinds of cancer seen among populations of different geographical areas. Dietary habits and, in particular, the nature and/or the amount of fat, calorie and/or vegetable fiber which are consumed in these countries are among the most frequently quoted etiological factors which may account for this situation. Epidemiological and experimental evidence has accumulated which, even though it can be used to support these conclusions, is still a matter of considerable debate. Modulation of neoplastic development is a concept which has been elaborated to overcome the fact that many experimental observations are not really taken into consideration by the classical 2-step theory of carcinogenesis. It is defined as the effect of any treatment which given before, during or after the initiation of a full carcinogenic process modifies the pattern of neoplastic development as evaluated by the kinetics of appearance, the incidence and/or the yield of histologically characterized malignant tumors. It is said to be positive or negative depending on whether it accelerates or slows down the process and increases or decreases the yield of malignant tumors respectively. From a review of the available experimental data, it is concluded that fat per se has, most probably, no modulating effect but that unbalanced diets rich in lipids could act as a positive modulator of chemically induced carcinogenesis by virtue of their capacity to cause a break in metabolic and proliferative homeostasis; that vegetable fibers as well as restriction in calorie intake could act as negative modulators of the same process because they could restore or help restore this homeostasis. It is thus proposed that to maintain dietary balance either by increasing fiber and/or by reducing total calorie intake is the most effective way to negatively modulate chemically induced carcinogenesis in experimental animals. To make the same recommendation to humans could most probably help preventing major cancers like breast and colon cancers.

Diet and cancer — experimental evidence

Summary There is much evidence that nutrients can influence the outcome of studies of carcinogenesis in experimental animals. At present, much of the information is contradictory and of uncertain relevance to man. This is because different nutrients appear to affect different stages of the cancerous process and there may be many interactions between the nutrients, and between the nutrients and the cancer-causing agents. It is unlikely that such agents will ever be entirely eliminated from the human diet but there is a real possibility that several classes of nutrients have a protective effect.

Retinoid‐enhanced gap junctional communication is achieved by increased levels of connexin 43 mRNA and protein

Natural and synthetic retinoids are potent inhibitors of experimental carcinogenesis in animals and cause reversion of premalignant lesions in humans. In the model C3H 10T1/2 cell system, retinoids enhance postconfluent growth control, reversibly inhibit carcinogen-induced transformation, and enhance gap junctional intercellular communication. These effects are highly correlated. 10T1/2 cells were found to express low levels of connexin 43, a gap junctional protein first found in the heart. After treatment of confluent 10T1/2 cells with the synthetic retinoid tetrahydrotetramethylnapthalenylpropenylbenzoic acid (TTNPB), levels of connexin 43 mRNA and protein increased within 6 h of treatment, while elevation of junctional communication was detected within 12-18 h. The maximally effective concentration of TTNPB (10(-8) M) caused an approximate 10-fold elevation of connexin 43 gene transcripts after 72 h. Indirect immunofluorescence microscopy using a polyclonal antibody to the synthetic C-terminal region of connexin 43 demonstrated that TTNPB induced many fluorescent plaques in regions of cell-cell contact. These results provide a molecular basis for the retinoid-enhanced junctional communication in 10T1/2 cells. It is proposed that one action of retinoids is to modulate the intercellular transfer of signal molecules. These could mediate many of the physiological actions of retinoids on growth control and carcinogenesis.

Chemoprevention of experimental carcinogenesis in animals

Retinoids are well-established chemopreventive agents for experimental carcinogenesis of many target organs including mammary glands, urinary bladder, lung, skin, liver, pancreas, colon, and esophagus. Modification of the basic retinoid structure has produced analogs with enhanced target organ specificity, increased inhibitory activity, and reduced toxicity. N-(4-hydroxyphenyl)retinamide (4-HPR) currently appears to be the most efficacious retinoid against carcinogen-induced breast, urinary bladder, and lung cancer in rodents. Retinoids are most effective when administered shortly after the carcinogen treatment; however, the treatment can be delayed significantly while maintaining its chemopreventive effect. Under various experimental conditions combining retinoid treatment with other modifiers of growth enhances its chemopreventive activity; for example retinoid plus hormonal modulation can provide better protection against mammary cancer than either treatment alone. More recently chemopreventive activity of various other classes of agents, such as thiols, phenols, antioxidants, inhibitors of prostaglandin synthesis, etc., have been investigated in experimental mammary, urinary bladder, and lung cancer models.

Radiation carcinogenesis in experimental animals.

Exposure of man to relatively high doses of ionizing radiation is generally restricted to accidental situations, with very limited knowledge about the actual doses received. Animal experiments can be performed under standardized and controlled conditions and can provide information on the dose-response relationships for radiation carcinogenesis. The risk of inducing neoplastic late effects after total-body irradiation with relatively high doses has been demonstrated for larger animals, such as monkeys and dogs. The bone marrow, the mammary glands and the lungs are among the tissues with the highest susceptibility for radiation carcinogenesis. Experimental results on tumour induction in rodents are summarized with emphasis on the effectiveness in dependence on radiation quality and fractionation or dose rate.

An illustration of dangers of ignoring survival differences in carcinogenic data.

This paper illustrates the effects of survival differences on the routine analysis of 2-year animal carcinogenesis experiments using quantal response. Not adjusting for decreased survival in the higher dosed groups results in a decrease in the actual significance level for the quantal response trend test, and a corresponding decrease in sensitivity for detecting a true treatment effect. Similar results hold for estimation of carcinogenic risk. Tables of the range of survival differences found in recent National Toxicology Program carcinogenesis studies are presented.

Successful use of short-term tests for academic purposes: Their use in identification of new environmental carcinogens with possible risk for humans

In the early 1970s, the short-term microbial mutation tests, particularly Ames' Salmonella test began to be used by workers in cancer research and environmental regulatory agencies (Ames, 1971; Ames et al., 1975; McCann et al., 1975). At that time, the public was much concerned with carcinogenesis resulting from pollution by chemical industries. Numerous new synthetic chemicals have been introduced into our environment and some of these were found to be carcinogenic to rodents and suspected to be carcinogenic to humans. These chemicals could not all be examined in long-term animal carcinogenesis experiments in rodents because of shortages of financial resources and more especially of qualified persons with the abifity to carry out the many necropsies and histological analyses required. So the introduction of short-term microbial mutation tests was very welcome in scientific circles. Earlier papers on the overlap of chemicals giving positive results for mutagenicity in short-term microbial mutation tests and showing carcinogenicity in long-term

Induction of single-strand breaks and interstrand cross-links in liver DNA after the administration of 2-acetylaminofluorene and trans-4-acetylaminostilbene to rats.

2-Acetylaminofluorene (AAF) or trans-4-acetylaminostilbene (AAS) was orally or intraperitoneally administered to female Wistar rats. DNA from liver cells was analyzed for single-strand breaks by the alkaline elution assay. Only borderline effects were observed with doses (100 mumol/kg) used in animal carcinogenesis experiments. Even high doses of AAF (1,000 mumol/kg) were not effective. Methyl methanesulfonate (MMS) in vivo and gamma irradiation in vitro were shown to produce dose-dependent DNA single-strand breaks (positive control). Only a marginal effect was obtained with 100 mumol/kg MMS. The elution rate of DNA was increased by a factor of 34 in liver cells in vitro with 400 rad of gamma irradiation. Only a fraction of this rate could be demonstrated immediately after irradiation in vivo, and no lesions were found two hours later. This strongly indicates the rapid repair of single-strand breaks. Additional experiments showed that AAS, a nonhepatocarcinogen, produced more interstrand cross-links in the rat liver DNA than did AAF.

Choline deficiency and chemical carcinogenesis.

We have reviewed the current status of our knowledge concerning the biologic effects of dietary choline (lipotrope) deficiency in modifying chemical carcinogenesis in experimental animals and discussed its possible mechanisms. Choline deficiency produces various pathologic lesions, involving virtually every organ of the body, as a result of a decrease in phospholipid and acetylcholine synthesis and in the supply of labile methyl groups. The liver is the only organ in which a relationship has been consistently demonstrated between choline deficiency and chemically induced tumors. The deficient diet enhances the initiating potency of several carcinogens and acts as a strong cocarcinogen. Diet also exerts a strong promoting effect, though the possibility that it is a complete carcinogen cannot be ruled out. Phase I enzymes of the carcinogen metabolizing system are uniformly depressed by choline deficiency, but very little information is available regarding the effects of diet on Phase II enzymes that detoxify carcinogen metabolites. Possible modifications of carcinogen-induced DNA damage and their repair processes have not been adequately scrutinized. Solid evidence suggests that feeding a choline-deficient diet leads to enhanced liver cell proliferation, an inadequate supply of methyl groups for transmethylation reactions, and membrane lipid peroxidation. Induced cell proliferation and hypomethylation of DNA may alter the state of gene expression, including that of specific cellular oncogenes. Lipid peroxidation may alter the structure and function of membrane receptors related to liver cell growth or may directly damage cellular DNA. Thus these alterations, individually or in combination, could play a critical role in the diet-induced modification of chemical carcinogenesis.

Estimating the tumour onset distribution in animal carcinogenesis experiments

SUMMARY In most survival-sacrifice experiments for the detection and quantification of risks from chronic exposure to chemical agents, the onset of the condition of interest is not clinically observable. Cancer is typically such an event. In this paper, an approximate maximum likelihood method is proposed for parametric estimation of the distribution of unobservable tumour onset times in the presence of competing risks, when cause-ofdeath information is unavailable.